Description
Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027
Market Overview
Worldwide it has been noticed that the cardiovascular information system market possesses a USD 1,560.93 million during the conjecture time of 2020 to 2027. It has been denoted that the cardiovascular information system market projects at a CAGR of 8.23%. Everywhere, it has been found that because of cardiovascular sickness many individuals have passed on because of heart-related infections.
The significant market driving elements are the ascent in the need to join CVIS with CPAS/EMR and different modules connected with cardiology to build the cardiovascular information system market size. Driving elements like interoperability, getting to the remote pictures and information, and limiting the responsibility of the IT area from the online emergency clinic is assisting in growing the cardiovascular information system with marketing size. The reception of CVIS coordinated arrangements because of its huge purchasing force of well-known emergency clinics and facilities expands the size of the cardiovascular information system market in this end-client order.
Market Segmentation
Based on type, the cardiovascular information system market is separated into CVIS and C-PACS. The CVIS division involves a huge market share from estimated time of 2015 to 2020. The CVIS area examines the information well and empowers the specialists to complete the ideal choice in very little time. In view of sections, the market is separated into programming, administration, and equipment.
Innovation progression of innovation prompted the utilization of imaging strategies for the treatment of related messes. Cutting-edge innovation has assisted in unique announcing of the pictures in the cardiovascular information system with marketing which has helped in conveying the reports of the patients.
Regional analysis
The cardiovascular information system market is extended to a great extent to the districts of North America coming after the European locale. Topographically, it has been denoted that this North American district is predominantly involved by severe protection and security guidelines and ascend in the extension of business in the cardiovascular information area. Universally, the North American locale has a medical services information system that has fostered its organization with merchants. Latin America is supposed to be somewhat in reverse than other arising nations yet is as yet encountering enormous potential for cardiovascular information system market development during the market figure period.
Major Players
The major market players of the global cardiovascular information system are GE, Koninklijke Philips N.V., McKesson Corporation, Siemens Healthineers, IBM Watson Health, Fujifilm Holdings Corporation, and Cerner Corporation.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contents
LIST OF CONTENTS
1 EXECUTIVE SUMMARY 18
2 MARKET INTRODUCTION 19
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 MARKET STRUCTURE 19
2.4 ASSUMPTIONS & LIMITATIONS 20
3 RESEARCH METHODOLOGY 21
3.1 DATA MINING 21
3.2 SECONDARY RESEARCH 22
3.3 PRIMARY RESEARCH 23
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26
3.6.1 BOTTOM-UP APPROACH 27
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS 29
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30
4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30
4.2.3 TECHNOLOGICAL ADVANCEMENTS 30
4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31
4.3 RESTRAINTS 32
4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32
4.3.2 RESTRAINT IMPACT ANALYSIS 32
4.4 OPPORTUNITIES 32
4.4.1 EMERGING MARKETS OF CVIS 32
5 MARKET FACTOR ANALYSIS 33
5.1 VALUE CHAIN ANALYSIS 33
5.1.1 R&D 34
5.1.2 MANUFACTURING 34
5.1.3 DISTRIBUTION AND SALES 34
5.1.4 POST-SALES MONITORING 34
5.2 PORTER’S FIVE FORCES MODEL 35
5.2.1 BARGAINING POWER OF SUPPLIERS 35
5.2.2 BARGAINING POWER OF BUYERS 36
5.2.3 THREAT OF NEW ENTRANTS 36
5.2.4 THREAT OF SUBSTITUTES 36
5.2.5 INTENSITY OF RIVALRY 36
5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36
5.3.1 OVERVIEW 36
5.3.2 IMPACT ON PRIVACY 37
5.3.3 IMPACT ON TECHNOLOGY 37
5.3.4 IMPACT ON DEMAND 37
6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38
6.1 OVERVIEW 38
6.2 SOFTWARE 39
6.3 SERVICES 39
6.4 HARDWARE 40
7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41
7.1 OVERVIEW 41
7.2 CLOUD-BASED/WEB-BASED 42
7.3 ON-PREMISE 42
8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43
8.1 OVERVIEW 43
8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44
8.3 ECHOCARDIOGRAPHY 45
8.4 HEMODYNAMICS MONITORING 45
8.5 ELECTROPHYSIOLOGY 46
8.6 VASCULAR ULTRASOUND 46
8.7 NUCLEAR CARDIOLOGY 47
8.8 ECG/STRESS/HOLTER MANAGEMENT 47
8.9 OTHERS 48
9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49
9.1 OVERVIEW 49
9.2 HOSPITAL & CLINICS 50
9.3 DIAGNOSTIC LABORATORIES 50
9.4 CARDIAC CATH LABS 51
9.5 OTHERS 51
10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52
10.1 OVERVIEW 52
10.2 AMERICAS 53
10.3 NORTH AMERICA 56
10.3.1 US 58
10.3.2 CANADA 59
10.3.3 LATIN AMERICA 61
10.4 EUROPE 63
10.4.1 WESTERN EUROPE 65
10.4.1.1 GERMANY 68
10.4.1.2 FRANCE 69
10.4.1.3 UK 71
10.4.1.4 ITALY 72
10.4.1.5 SPAIN 74
10.4.1.6 REST OF WESTERN EUROPE 76
10.4.2 EASTERN EUROPE 77
10.5 ASIA-PACIFIC 79
10.5.1 CHINA 81
10.5.2 INDIA 83
10.5.3 JAPAN 84
10.5.4 AUSTRALIA 86
10.5.5 SOUTH KOREA 87
10.5.6 REST OF ASIA-PACIFIC 89
10.6 MIDDLE EAST & AFRICA 90
10.6.1 MIDDLE EAST 93
10.6.2 AFRICA 94
11 COMPETITIVE LANDSCAPE 96
11.1 OVERVIEW 96
11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96
11.3 COMPETITIVE BENCHMARKING 97
11.4 COMPETITOR DASHBOARD 98
11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98
11.5.1 ACQUISITION 98
11.5.2 COLLABORATION 99
11.5.3 PRODUCT LAUNCH 99
11.5.4 PARTNERSHIP 99
11.6 FINANCIAL MATRIX 100
12 COMPANY PROFILES 101
12.1 GE HEALTHCARE 101
12.1.1 COMPANY OVERVIEW 101
12.1.2 FINANCIAL OVERVIEW 102
12.1.3 PRODUCTS/SERVICES OFFERED 102
12.1.4 KEY DEVELOPMENTS 103
12.1.5 SWOT ANALYSIS 103
12.1.6 KEY STRATEGIES 103
12.2 SIEMENS HEALTHINEERS 104
12.2.1 COMPANY OVERVIEW 104
12.2.2 FINANCIAL OVERVIEW 105
12.2.3 PRODUCTS/SERVICES OFFERED 105
12.2.4 KEY DEVELOPMENTS 106
12.2.5 SWOT ANALYSIS 106
12.2.6 KEY STRATEGIES 106
12.3 KONINKLIJKE PHILIPS NV 107
12.3.1 COMPANY OVERVIEW 107
12.3.2 FINANCIAL OVERVIEW 108
12.3.3 PRODUCTS/SERVICES OFFERED 108
12.3.4 KEY DEVELOPMENTS 109
12.3.5 SWOT ANALYSIS 109
12.3.6 KEY STRATEGIES 109
12.4 FUJIFILM HOLDINGS CORPORATION 110
12.4.1 COMPANY OVERVIEW 110
12.4.2 FINANCIAL OVERVIEW 111
12.4.3 PRODUCTS/SERVICES OFFERED 111
12.4.4 KEY DEVELOPMENTS 112
12.4.5 SWOT ANALYSIS 112
12.4.6 KEY STRATEGIES 112
12.5 MCKESSON CORPORATION 113
12.5.1 COMPANY OVERVIEW 113
12.5.2 FINANCIAL OVERVIEW 114
12.5.3 PRODUCTS/SERVICES OFFERED 114
12.5.4 KEY DEVELOPMENTS 115
12.5.5 SWOT ANALYSIS 115
12.5.6 KEY STRATEGIES 116
12.6 CERNER CORPORATION 117
12.6.1 COMPANY OVERVIEW 117
12.6.2 FINANCIAL OVERVIEW 117
12.6.3 PRODUCTS OFFERED 118
12.6.4 KEY DEVELOPMENTS 118
12.6.5 SWOT ANALYSIS 119
12.6.6 KEY STRATEGIES 119
12.7 IBM WATSON HEALTH 120
12.7.1 COMPANY OVERVIEW 120
12.7.2 FINANCIAL OVERVIEW 121
12.7.3 PRODUCTS OFFERED 121
12.7.4 KEY DEVELOPMENTS 122
12.7.5 SWOT ANALYSIS 122
12.7.6 KEY STRATEGIES 123
12.8 LUMEDX 124
12.8.1 COMPANY OVERVIEW 124
12.8.2 FINANCIAL OVERVIEW 124
12.8.3 PRODUCTS OFFERED 124
12.8.4 KEY DEVELOPMENTS 124
12.8.5 SWOT ANALYSIS 125
12.8.6 KEY STRATEGIES 125
12.9 AGFA-GEVAERT N.V. 126
12.9.1 COMPANY OVERVIEW 126
12.9.2 FINANCIAL OVERVIEW 126
12.9.3 PRODUCTS OFFERED 126
12.9.4 KEY DEVELOPMENTS 127
12.9.5 SWOT ANALYSIS 127
12.9.6 KEY STRATEGIES 127
12.10 DIGISONICS INC. 128
12.10.1 COMPANY OVERVIEW 128
12.10.2 FINANCIAL OVERVIEW 128
12.10.3 PRODUCTS OFFERED 128
12.10.4 KEY DEVELOPMENTS 128
12.10.5 SWOT ANALYSIS 129
12.10.6 KEY STRATEGIES 129
12.11 CARESTREAM HEALTH 130
12.11.1 COMPANY OVERVIEW 130
12.11.2 FINANCIAL OVERVIEW 130
12.11.3 PRODUCTS/SERVICES OFFERED 130
12.11.4 KEY DEVELOPMENTS 130
12.11.5 SWOT ANALYSIS 131
12.11.6 KEY STRATEGIES 131
12.12 EPIC SYSTEMS CORPORATION 132
12.12.1 COMPANY OVERVIEW 132
12.12.2 FINANCIAL OVERVIEW 132
12.12.3 PRODUCTS OFFERED 132
12.12.4 KEY DEVELOPMENTS 132
12.12.5 SWOT ANALYSIS 133
12.12.6 KEY STRATEGIES 133
12.13 SCIMAGE, INC. 134
12.13.1 COMPANY OVERVIEW 134
12.13.2 FINANCIAL OVERVIEW 134
12.13.3 PRODUCTS/SERVICES OFFERED 134
12.13.4 KEY DEVELOPMENTS 134
12.13.5 SWOT ANALYSIS 135
12.13.6 KEY STRATEGIES 135
13 APPENDIX 136
13.1 REFERENCES 136
13.2 RELATED REPORTS 136
Reviews
There are no reviews yet.